glp-1 news today cardiovascular outcomes 2025 november Studies Add to Growing Body of Evidence Demonstrating Significant Benefit on The GLP-1 Revolution Continues

In oncology , Keytruda appears to have peaked and faces challenges from patent expirations and emerging therapies such as bispecific antibodies

Different GLP-1 medications have different flexibility built into their approved dosing schedules

This discovery formed the scientific basis for the development of AOD-9604 as a focused research tool for metabolic biology investigation

Changes in pigment profiles of Haematococcus pluvialis during exposure to environmental stresses

Patients had a nine times greater likelihood of a gastroparesis diagnosis

An update on potential biomarkers for diagnosing diabetic foot ulcer at early stage